These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 1165516

  • 1. Minimal-lesion nephrotic syndrome with early resistance to steroid therapy.
    Siegel NJ, Gur A, Krassner LS, Kashgarian M.
    J Pediatr; 1975 Sep; 87(3):377-80. PubMed ID: 1165516
    [Abstract] [Full Text] [Related]

  • 2. Late nonresponsiveness to steroids in children with the nephrotic syndrome.
    Trainin EB, Boichis H, Spitzer A, Edelmann CM, Greifer I.
    J Pediatr; 1975 Oct; 87(4):519-23. PubMed ID: 1159578
    [Abstract] [Full Text] [Related]

  • 3. Steroid-responsive nephrotic syndrome of childhood: a long-term study of clinical course, histopathology, efficacy of cyclophosphamide therapy, and effects on growth.
    Berns JS, Gaudio KM, Krassner LS, Anderson FP, Durante D, McDonald BM, Siegel NJ.
    Am J Kidney Dis; 1987 Feb; 9(2):108-14. PubMed ID: 3826059
    [Abstract] [Full Text] [Related]

  • 4. Nephrotic syndrome in African children: lack of evidence for 'tropical nephrotic syndrome'?
    Doe JY, Funk M, Mengel M, Doehring E, Ehrich JH.
    Nephrol Dial Transplant; 2006 Mar; 21(3):672-6. PubMed ID: 16326742
    [Abstract] [Full Text] [Related]

  • 5. [Idiopathic nephrotic syndrome with minimal glomerular lesions in children (author's transl)].
    Scharer K, Gilli G.
    Ateneo Parmense Acta Biomed; 1975 Mar; 46(5):455-71. PubMed ID: 1232998
    [Abstract] [Full Text] [Related]

  • 6. Treatment of the idiopathic nephrotic syndrome.
    Kleinknecht C, Broyer M, Jarde O, Guillot M.
    Paediatrician; 1981 Mar; 10(5-6):382-99. PubMed ID: 7036046
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y.
    Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
    [Abstract] [Full Text] [Related]

  • 8. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
    Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L.
    Nephrology (Carlton); 2015 Jan; 20(1):18-24. PubMed ID: 25312783
    [Abstract] [Full Text] [Related]

  • 9. Beneficial effect of second courses of cytotoxic therapy in children with minimal change nephrotic syndrome.
    Jones DP, Stapleton FB, Roy S, Wyatt RJ.
    Pediatr Nephrol; 1988 Jul; 2(3):291-5. PubMed ID: 3153028
    [Abstract] [Full Text] [Related]

  • 10. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R, Pirisi M, Satta A, Tanda F, Bartoli E.
    Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
    [Abstract] [Full Text] [Related]

  • 11. Late resistance to corticosteroids in nephrotic syndrome.
    Srivastava RN, Agarwal RK, Moudgil A, Bhuyan UN.
    J Pediatr; 1986 Jan; 108(1):66-70. PubMed ID: 3944696
    [Abstract] [Full Text] [Related]

  • 12. Cyclophosphamide therapy in frequently relapsing nephrotic syndrome with and without steroid dependence.
    Srivastava RN, Agarwal RK, Choudhry VP, Moudgil A, Bhuyan UN, Sunderam KR.
    Int J Pediatr Nephrol; 1985 Jan; 6(4):245-50. PubMed ID: 4093243
    [Abstract] [Full Text] [Related]

  • 13. Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie.
    Arch Dis Child; 1987 Nov; 62(11):1102-6. PubMed ID: 3688915
    [Abstract] [Full Text] [Related]

  • 14. Cyclophosphamide therapy in the nephrotic syndrome in childhood.
    Moncrieff MW, White RH, Oggs CS, Cameron JS.
    Br Med J; 1969 Mar 15; 1(5645):666-71. PubMed ID: 5774315
    [Abstract] [Full Text] [Related]

  • 15. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
    Am J Kidney Dis; 2009 Jul 15; 54(1):51-8. PubMed ID: 19406543
    [Abstract] [Full Text] [Related]

  • 16. Pattern of response to prednisone in idiopathic, minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy.
    Garin EH, Pryor ND, Fennell RS, Richard GA.
    J Pediatr; 1978 Feb 15; 92(2):304-8. PubMed ID: 621614
    [Abstract] [Full Text] [Related]

  • 17. Childhood nephrotic syndrome: clinical associations and response to therapy.
    Grupe WE.
    Postgrad Med; 1979 May 15; 65(5):229-31, 234-6. PubMed ID: 432155
    [Abstract] [Full Text] [Related]

  • 18. Cyclophosphamide in the treatment of focal segmental glomerulosclerosis.
    Martinelli R, Pereira LJ, Silva OM, Okumura AS, Rocha H.
    Braz J Med Biol Res; 2004 Sep 15; 37(9):1365-72. PubMed ID: 15334202
    [Abstract] [Full Text] [Related]

  • 19. Adult-onset nephrotic syndrome with minimal changes: response to corticosteroids and cyclophosphamide.
    Nolasco F, Cameron JS, Hicks J, Ogg CS, Williams DG.
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985 Sep 15; 21():588-93. PubMed ID: 3991549
    [Abstract] [Full Text] [Related]

  • 20. The significance of focal sclerotic lesions of glomeruli in children.
    Nash MA, Greifer I, Olbing H, Bernstein J, Bennett B, Spitzer A.
    J Pediatr; 1976 May 15; 88(5):806-13. PubMed ID: 1271143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.